Premium Rx National LLC

PRN Pharmaceuticals is a trusted and reliable provider of pharmaceutical solutions, specializing in addressing drug supply challenges for hospitals, surgery centers, and government facilities. With their extensive network and partnerships, they ensure continuous access to essential medications, offering a diverse range of brand name and generic pharmaceuticals, biologics, vaccines, and over-the-counter products. As an authorized distributor for leading manufacturers, PRN Pharmaceuticals goes above and beyond to meet the needs of their clients, providing professional service and industry insights. Their compliance programs exceed the requirements of the DSCSA, allowing customers access to a secure and confidential online portal for transaction information. With their unwavering support and timely interventions, PRN Pharmaceuticals helps healthcare facilities navigate supply issues with ease, ensuring consistent patient care.Generated from the website

Epl Archives is a document management company based in Sterling, VA, specializing in archival services for businesses and organizations. They offer secure storage, digitization, and retrieval solutions to help clients efficiently manage their records and information. Generated from their business information

Quoin Pharmaceuticals Ltd is a biopharmaceutical company based in Ashburn, VA, dedicated to developing therapeutic products for rare diseases. With a strong focus on patient well-being, the company aims to address the challenges faced by individuals living with rare diseases, such as Netherton Syndrome, which affects approximately 300 million people worldwide. Quoin Pharmaceuticals is conducting ongoing clinical trials for QRX003, a potential treatment for Netherton Syndrome, and has established exclusive international marketing and distribution partnerships to ensure global accessibility to their rare disease products. Driven by the courage of patients, their families, and care teams, Quoin Pharmaceuticals is motivated to make a positive impact in the field of rare diseases. Their business strategy revolves around placing patients at the center of their operations, with plans to establish a commercial infrastructure in the US and Europe. Committed to innovation, the company has filed patent applications for a novel combination product for Netherton Syndrome, further demonstrating their dedication to improving the lives of those affected by rare diseases.Generated from the website